Alongside these presentations, Eikon will also share additional milestone updates across its broad and diverse research and development pipeline. “We are encouraged by the progress we are seeing ...

CHICAGO--(BUSINESS WIRE)--Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with traditional biology research to accelerate ...

Eikon Therapeutics Inc. cut 55 jobs from its Millbrae facility, according to a WARN notice filed with the Employment Development Department. Led by a former Merck executive and headquartered in ...

Willie was outside playing basketball, Soup was just starting Eikon Ministries. “If this man hadn’t saw the potential for me in my life enough to take me under his wing and to mentor disciple ...

SDVI, a platform provider for cloud-native media supply chains, has integrated its Rally media supply chain management platform with the new EIKON-iQ intelligent integration gateway to enable full ...

Biotechnology company Eikon Therapeutics announced the initial closing of a $350.7 million Series D financing round that it will use to advance its clinical-stage programs. The new funding brings ...

US-based biotech Eikon Therapeutics has raised $350.7m in funding to advance its portfolio of cancer candidates. The company’s lead asset, EIK1001, is a systemically administered Toll-like ...

Eikon Therapeutics is no stranger to eye-popping funding rounds, and the cancer-focused biotech has continued this trend with a $350.7 million series D to fuel its various clinical trials.

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Eikon Therapeutics, a well-funded drug startup run by Merck & Co.’s former research chief, has raised ...

The upward trajectory continues for Eikon Therapeutics, which announced that it has raised $351 million to fund various cancer related clinical trials. The Series D funding unveiled Wednesday morning ...

The funding, led by existing and new investors, is expected to support Eikon’s efforts to integrate advanced computing, automation, and data science that drives innovation in drug development. Eikon ...